Your search returned 90 studies. (Get alerts for new studies):
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Carthage, Illinois
- Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
Conditions: Leukemia - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
Location: Carthage, Illinois
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
Conditions: Lymphoma
Location: Carthage, Illinois
- Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
Conditions: Lymphoma
Location: Carthage, Illinois
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
Conditions: Esophageal Cancer
Location: Carthage, Illinois
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Carthage, Illinois
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Carthage, Illinois
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: Carthage, Illinois
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: Carthage, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Carthage, Illinois
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Carthage, Illinois
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Carthage, Illinois
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Carthage, Illinois
- Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carbopla
Conditions: Lung Cancer - Non Small Cell
Location: Quincy, Illinois
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Carthage, Illinois
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Carthage, Illinois
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Carthage, Illinois
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Stage I Bladder Cancer - Stage II Bladder Cancer - Stage III Bladder Cancer - Transitional Cell Carcinoma of the Bladder
Location: Carthage, Illinois
- Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Conditions: Stage I Bladder Cancer - Stage II Bladder Cancer - Stage III Bladder Cancer - Transitional Cell Carcinoma of the Bladder
Location: Carthage, Illinois
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Carthage, Illinois
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Carthage, Illinois
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Carthage, Illinois
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Stage IB Non-small Cell Lung Cancer - Stage IIA Non-small Cell Lung Cancer - Stage IIB Non-small Cell Lung Cancer - Stage IIIA Non-small Cell Lung Cancer
Location: Carthage, Illinois
- Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma - Recurrent Renal Cell Cancer - Stage III Renal Cell Cancer - Stage IV Renal Cell Cancer
Location: Carthage, Illinois
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Carthage, Illinois
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
Location: Carthage, Illinois
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Carthage, Illinois
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Stage I Multiple Myeloma - Stage II Multiple Myeloma - Stage III Multiple Myeloma
Location: Carthage, Illinois
- BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non
Conditions: Lung Cancer
Location: Carthage, Illinois
- Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: Carthage, Illinois
- Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Location: Carthage, Illinois
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Carthage, Illinois
- Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia
Conditions: Leukemia
Location: Carthage, Illinois
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Carthage, Illinois
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer - Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter - Proximal Urethral Cancer - Recurrent Bladder Cancer - Recurrent Prostate Cancer - Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter - Recurrent U
Location: Carthage, Illinois
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Carthage, Illinois
- S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Carthage, Illinois
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: Carthage, Illinois
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors - Neurotoxicity
Location: Carthage, Illinois
- Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors - Neurotoxicity
Location: Carthage, Illinois
- Lisinopril or Carvedilol Phosphate in Reducing Side Effects in Women With HER2-Positive Breast Cancer Receiving Trastuzumab
Conditions: Breast Cancer - Cardiac Toxicity
Location: Carthage, Illinois
- Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Carthage, Illinois
- Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Carthage, Illinois
- This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
Conditions: Heart Failure With Reduced Ejection Fraction
Location: Quincy, Illinois
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Carthage, Illinois
- GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line
Conditions: Non Small Cell Lung Cancer
Location: Carthage, Illinois
- A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Ind
Conditions: Non-Hodgkin's Lymphoma
Location: Quincy, Illinois
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
Location: Carthage, Illinois
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
Location: Carthage, Illinois
- Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
Conditions: Malignant Mesothelioma
Location: Carthage, Illinois
- Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Conditions: Breast Cancer
Location: Carthage, Illinois
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Carthage, Illinois
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Carthage, Illinois
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Carthage, Illinois
- Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
Conditions: Kidney Cancer
Location: Carthage, Illinois
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Carthage, Illinois
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Carthage, Illinois
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Conditions: Light Chain Deposition Disease - Smoldering Multiple Myeloma
Location: Carthage, Illinois
- Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Conditions: Light Chain Deposition Disease - Smoldering Multiple Myeloma
Location: Carthage, Illinois
- Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-
Conditions: Lymphoma
Location: Carthage, Illinois
- Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Carthage, Illinois
- Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
Conditions: Recurrent Prostate Cancer - Stage I Prostate Cancer - Stage IIA Prostate Cancer - Stage IIB Prostate Cancer - Stage III Prostate Cancer
Location: Carthage, Illinois
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Carthage, Illinois
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma - Stage IIIB Melanoma - Stage IIIC Melanoma - Stage IV Melanoma
Location: Carthage, Illinois
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Carthage, Illinois
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Carthage, Illinois
- Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders
Location: Carthage, Illinois
- Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
Conditions: Breast Cancer - Depression - Fatigue - Sleep Disorders
Location: Carthage, Illinois
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Quincy, Illinois
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Carthage, Illinois
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
Location: Carthage, Illinois
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Carthage, Illinois
- Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Pa
Conditions: Lymphoma
Location: Carthage, Illinois
- Magnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast Cancer
Conditions: Breast Cancer - Cancer Survivor - Hot Flashes
Location: Carthage, Illinois
- Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinu
Conditions: Small Cell Lung Carcinoma
Location: Quincy, Illinois
- A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Conditions: Ulcerative Colitis
Location: Hannibal, Missouri
- A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Conditions: Ulcerative Colitis
Location: Hannibal, Missouri
- Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Dr
Conditions: Arthritis, Psoriatic
Location: Quincy, Illinois
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
Location: Carthage, Illinois
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction - Esophageal Cancer - Gastric Cancer
Location: Carthage, Illinois
- Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Conditions: Ulcerative Colitis
Location: Hannibal, Missouri
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Carthage, Illinois
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Carthage, Illinois
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Carthage, Illinois
- PROMUS Element Plus US Post-Approval Study
Conditions: Coronary Artery Disease
Location: Quincy, Illinois
- Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery
Conditions: Adult Angiosarcoma - Recurrent Adult Soft Tissue Sarcoma - Stage III Adult Soft Tissue Sarcoma - Stage IV Adult Soft Tissue Sarcoma
Location: Carthage, Illinois
- Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery
Conditions: Adult Angiosarcoma - Recurrent Adult Soft Tissue Sarcoma - Stage III Adult Soft Tissue Sarcoma - Stage IV Adult Soft Tissue Sarcoma
Location: Carthage, Illinois
- Strategies Using Darbepoetin Alfa to Avoid Transfusions in Chronic Kidney Disease
Conditions: Management of Anemia in Chronic Kidney Disease Patients Not on Dialysis.
Location: Quincy, Illinois
- A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB in Patients With COPD Who Have Moderate to Severe
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Quincy, Illinois
- Armodafinil in Reducing Cancer-Related Fatigue in Patients With Glioblastoma Multiforme
Conditions: Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Fatigue
Location: Carthage, Illinois
|